Whitehawk Therapeutics (WHWK) EBT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -32.30% |
| Dec 31, 2025 | 61.01% |
| Sep 30, 2025 | -43.67% |
| Jun 30, 2025 | -50.37% |
| Mar 31, 2025 | 82.53% |
| Dec 31, 2024 | -32.41% |
| Sep 30, 2024 | -21.55% |
| Jun 30, 2024 | -20.71% |
| Mar 31, 2024 | -16.54% |
| Dec 31, 2023 | -13.81% |
| Sep 30, 2023 | -27.83% |
| Jun 30, 2023 | -24.57% |
| Mar 31, 2023 | -15.44% |
| Dec 31, 2022 | -17.43% |
| Sep 30, 2022 | -25.25% |
| Jun 30, 2022 | -26.98% |
| Mar 31, 2022 | -22.46% |
| Dec 31, 2021 | -35.23% |
| Sep 30, 2021 | -77.70% |
| Jun 30, 2021 | 19.25% |
| Mar 31, 2021 | -5.42% |
| Dec 31, 2020 | 268.54% |
| Sep 30, 2020 | -238.33% |
| Jun 30, 2020 | 318.10% |
| Mar 31, 2020 | -269.38% |
| Dec 31, 2019 | -228.96% |
| Sep 30, 2019 | -274.37% |
| Jun 30, 2019 | -282.45% |
| Mar 31, 2019 | -330.32% |
| Dec 31, 2018 | -287.50% |
| Sep 30, 2018 | 351.70% |
| Jun 30, 2018 | -288.72% |
| Mar 31, 2018 | -314.58% |
| Dec 31, 2017 | -264.72% |
| Sep 30, 2017 | -278.59% |
| Jun 30, 2017 | -287.85% |
| Mar 31, 2017 | -293.07% |
| Dec 31, 2016 | -230.74% |
| Sep 30, 2016 | -278.37% |
| Jun 30, 2016 | -266.48% |
| Mar 31, 2016 | -282.26% |
| Dec 31, 2015 | -8.84% |
| Sep 30, 2015 | -6.47% |